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For most of human evolution, the scarcity of food and the rotation of the earth have exerted selective pressures that have shaped biology (Bass and Lazar, 2016) . In contrast, today, the populations of economically developed countries are experiencing an epidemic of obesity and metabolic disease due to the availability of calorie-dense foods at all hours of the day and night. A detailed understanding of the impact of diet, body composition, and disruption of the normal day/night cycle on human health is needed to combat this growing medical challenge.
The medical importance of the discovery of the molecular underpinnings of the circadian clock, first in Drosophila and subsequently in most species, including humans, was highlighted by the 2017 Nobel Prize in Physiology or Medicine to Hall, Rosbash, and Young. While it has long been known that organisms including humans have internal rhythms, it was not until the work of Konopka and Benzer that a genetic basis for these rhythms was found with the identification of clock mutants in Drosophila (Konopka and Benzer, 1971) . Subsequent work showed that the cellular clock operates through a mechanism involving connected positive and negative transcriptional feedback loops that lead to an oscillation of expression of core circadian transcription factors with a period of about 24 hr. Versions of this clock exist throughout the cells of the body including those of the liver and constitute so-called peripheral clocks. In humans and most other mammals, these peripheral clocks are synchronized through the activity of a central clock located in the suprachiasmatic nucleus of the hypothalamus that is reset daily by light (Takahashi, 2017) .
Given the key role of the liver in regulating metabolism, it is significant that disruption of the liver clock genetically or secondarily through disruption of central signals leads to metabolic derangements including fatty liver (Feng and Lazar, 2012) . Work on the link between the liver clock and metabolic alterations has implicated additional transcriptionally regulated negative feedback loops involving the Rev-erb nuclear receptors (NR1D1 and NR1D2) as core clock components as well as other transcription factors that act during different phases of the clock. In addition, these studies demonstrated a link between the action of Rev-erb and the histone deacetylase HDAC3 and changes in the histone acetylation of the regulatory regions of genes expressed in a circadian fashion. Deletion of Rev-erb or HDAC3 in mouse liver leads to liver steatosis and metabolic changes associated with non-alcoholic fatty liver disease (Lazar, 2016) .
In this issue of Cell, Guan et al. investigate the impact of diet-induced obesity on the peripheral clock and its output in the liver (Guan et al., 2018) . Using global run-on sequencing (GRO-seq), a genome-wide approach to identify regions of active transcription in the genome, the authors identify both the bodies of transcribed genes and the transcription of enhancer RNA (eRNA) that mark the cis-regulatory regions of active genes. The power of characterizing a large set of coordinately regulated enhancers allowed the authors to identify significantly enriched transcription factor DNA-binding motifs. This analysis identified the DNA-binding motif for SREBP1, a key regulator of lipid metabolism genes, as being enriched in the enhancers of genes that demonstrated increased circadian expression in the setting of dietinduced obesity. They show that SREBP1 itself becomes circadian in its expression perhaps as a result of its own feedforward regulation and that the ability of dietinduced obesity to induce the fatty acid synthesis program in a circadian fashion depends on the activation of SREBP1 downstream of Scap.
More surprisingly, the authors also found that diet-induced obesity increased the circadian expression of genes associated with fatty acid oxidation (FAO) and evidence that these genes are regulated by the nuclear receptor PPARa. Using both genetic approaches and exogenously administered PPARa ligands, the authors show that the activation of FAO depends on PPARa and not related members of the PPAR family. In addition, they show that SREB1 activation of fatty acid synthesis genes involved in the generation of endogenous PPARa ligands precedes and is required for PPARa activation and increased expression of FAO genes. This suggests that the activation of the FAO program may be a homeostatic response to the increase in fatty acid synthesis.
The concept of chronotherapy, administering drugs at specific times of the day to maximize efficacy and minimize toxicity, is appealing (Ohdo, 2010) . This paper provides a potential example of one such approach targeting PPARa for the control of hyperlipidemia. While the efficacy of the PPARa ligand correlates with the peak levels of PPARa, it is possible that circadian changes in drug metabolism might also influence the peak time of its activity. A recent study of human transcriptional rhythms also identified PPARa to be circadian in its expression in human liver (Anafi et al., 2017) . Whether this is impacted by obesity or diet remains to be elucidated. In order to fulfill the promise of chronotherapy, a more detailed knowledge is needed of the impact of circadian rhythms on the expression and activity of a drug target, the pharmacokinetics and metabolism of the drug and the potential for the expression of unwanted targets in both the target tissue and the tissues responsible for toxicity. Obtaining these data around the clock in model organisms such as mice is feasible. However, obtaining significant numbers of samples for analysis from people will be a challenge. It is likely that the general concepts learned from the model organisms will also be true in humans, though important species-specific differences including known differences in drug metabolism are likely to be present.
Several other interesting questions are raised by this study. The authors utilize a model of diet-induced obesity in which the diet was high in fat and sucrose. It remains to be determined whether specific dietary constituents, obesity, or both independently influence the circadian changes described. While the study clearly shows that diet-induced obesity induces profound changes in circadian gene expression, the components of the core clock that are required for this change remains to be determined. Another hypothesis worth exploring would be that metabolites altered by the change in diet or body composition influence the activity of enzymes involved in chromatin modification and that these influence the activity of circadian enhancers (Sassone-Corsi, 2016) . Circadian metabolomic studies combined with studies of chromatin modification in models of diet-induced obesity around the clock could address this idea (Krishnaiah et al., 2017) . These mechanistic details notwithstanding, this study substantially enhances our understanding of how diet-induced obesity alters the circadian epigenome and transcriptome to exert major effects on metabolism.
Viruses have evolved inhibitors to counteract the CRISPR immune response, but they are not fully potent and need some time to be expressed after the beginning of infection. In this issue of Cell, Borges et al. and Landsberger et al. show that sequential infection gradually immunosuppresses the host to allow effective CRISPR inhibition.
Bacteria and the viruses that infect them, known as bacteriophages, have co-evolved over billions of years, giving rise to myriad innovative defensive and offensive strategies to combat one another. The most recent anti-phage defense systems to be thoroughly characterized are CRISPR-Cas systems that protect the bacterial host via cleavage of viral nucleic acid. All CRISPR loci contain a set of associated (cas) genes and an array containing sequences derived from foreign nucleic acids (spacers). Transcription and processing of spacer sequences in the array produces short CRISPR RNAs
